Image source: Getty Images
Zip Co Ltd (ASX: ZIP)
The Zip share price is $2.85, up 10.5% today and down 6% over 12 months.
Citi reiterated its buy rating on Zip shares after the buy now, pay later company's FY26 report.
The broker has a price target of $3.55.
This implies potential capital gains of 25% ahead for the ASX 200 financial share.
BHP Group Ltd (ASX: BHP)
The BHP share price is $65.26, up 2.4% today and up 56% over 12 months.
Morgan Stanley renewed its buy rating on BHP shares after the miner's FY26 report.
The broker increased its 12-month price target from $67 to $67.50.
This suggests a potential 3% upside ahead.
Hub24 Ltd (ASX: HUB)
The Hub24 share price is $76.22, down 4.4% today and down 27% over 12 months.
Morgan Stanley renewed its buy rating on Hub24 shares after the company's FY26 report.
The broker has a $121 target, which suggests a potential 58% upside ahead.
Santos Ltd (ASX: STO)
The Santos share price is $8.45, up 1.7% today and up 12% over 12 months.
Citi reaffirmed its buy rating on the ASX 200 energy share yesterday.
This followed Santos' 1H FY26 report.
The broker raised its 12-month target from $8.30 to $9.
This suggests a potential 6% upside ahead.
Coles Group Ltd (ASX: COL)
The Coles share price is $23.07, down 0.9% today and up 8% over 12 months.
Citi renewed its buy rating on Coles shares this week.
The broker has a $23 target on the ASX 200 consumer staples share.
This implies the stock is already fully valued.
Coles will report its FY26 earnings next Tuesday, 25 August.
Telix Pharmaceuticals Ltd (ASX: TLX)
The Telix Pharmaceuticals share price is $17.54, up 4% today and up 4% over 12 months.
Bell Potter reiterated its buy call on the ASX 200 healthcare share after reviewing the company's 1H FY26 report.
The broker has a price target of $19, which implies a potential 8% upside ahead.
Insurance Australia Group Ltd (ASX: IAG)
The IAG share price is $7.86, down 3.6% today and down 14% over 12 months.
Jefferies renewed its buy rating on IAG shares after reviewing the insurer's FY26 report.
The broker shaved its 12-month price target from $9.45 to $9.25.
This suggests a potential 17% upside ahead.
